BVI Acquires Arcadophtha (Arcad) SARL

B2B Training: What’s the Most Effective Way of Learning?

B2B training, which is short for business-to-business training, is a popular and convenient type of training that enables entire companies to train their teams...

AlixPartners Forecasts: Household Products Could Cost U.S. Manufacturers and Consumers 15% More This Year Due to Resin Shortage

While companies can’t control the market forces at play, they can take action to mitigate the risk and impact of supply chain disruption.

December 6, 2020: BVI, one of the fastest-growing diversified companies in ophthalmology, today announced it has acquired Arcadophtha SARL (Arcad), a France-based ophthalmic company specializing in silicon oils, gases and perfluorocarbons used in vitreoretinal surgery. Growth of the Arcad products will be accelerated through BVI’s broad-reaching commercial infrastructure established with the Vitreq line of vitreoretinal surgical products.

The transaction has closed during the 4th quarter of 2019 and financial terms of the transaction were not disclosed.  Arcad was acquired from its founders, who will continue to support the business.

“We are pleased to welcome the Arcad team to our organization. The products fit extremely well alongside our current vitreoretinal product offering.  Arcad’s unmatched focus on product quality and vertically-integrated business model aligns well with BVI’s business philosophy,” said Shervin Korangy, President and CEO of BVI. “Vitreoretinal surgery is a strategic segment for BVI and Arcad’s products will further strengthen our ability to meet the needs of our customers.”

Arcad has developed a proprietary process of purification and fractionation that delivers high-quality products for use by surgeons. Additionally, the company has developed certain single-use and easy to administer delivery systems for products.  Arcad brings over 25 years of expertise in the ophthalmic space and a strong history in close collaboration with surgeons worldwide.

“We are thrilled to partner with BVI and firmly believe that our combined offering of physician-preferred products will continue to contribute to outstanding patient outcomes,” said Gerard Reboul, Co-founder of Arcad. “BVI’s emphasis on innovative and differentiated products culturally aligns with our organization.”



Mediclinic Appoints 2 New Independent Non-Executive Directors

Natalia Barsegiyan and Zarina Bassa will bring significant and diverse skills and experience, complementing those of existing Board members. I am confident they will both be great additions to our Board of Directors.”

Asensus Surgical Appoints Two New Board Members

Asensus Surgical, Inc. (NYSE American: ASXC), a medical device company that is digitizing the interface between the surgeon and the patient to pioneer a new era of Performance-Guided Surgery™, today announced the expansion of its Board of Directors, appointing...

Our Sister Publication: Biotechnology News Magazine

Subscribe to Medical Device News Magazine here.